Stallion India Fluorochemicals is set to launch its initial public offering (IPO) from January 16 to January 20, 2025, aiming to raise approximately ₹199.45 crores. The IPO will consist of a fresh issue of equity shares priced between ₹85 and ₹90 each, with a face value of ₹10. Established in 2002, Stallion India specializes in the sale of refrigerant and industrial gases, serving various sectors including automotive and electronics. The proceeds from the IPO will be utilized for capital expenditures aimed at enhancing production capabilities and meeting working capital needs.
₹40
₹90
₹120.00
Expert Opinions
Market sentiment for the Stallion India IPO is cautiously optimistic, reflecting interest in the chemical sector despite some volatility in broader equity markets. Stallion India Fluorochemicals has established a strong foothold in the refrigerant and industrial gases market, showcasing a diverse product portfolio that serves various industries, including automotive and semiconductor manufacturing. However, potential risks include fluctuations in raw material prices and regulatory changes that could impact operational costs and market demand.
Valuation Analysis, The company has demonstrated steady revenue growth, with revenues increasing from ₹1,858.8 million in FY2022 to ₹2,362.3 million in FY2024, indicating a compound annual growth rate (CAGR) of approximately 10.9%. From a long-term investment perspective, Stallion India is well-positioned to benefit from the growing demand for refrigerants and industrial gases.
Investor Considerations
Investors considering the Stallion India IPO should analyze several key factors. Company performance and fundamentals indicate steady growth, with revenues increasing from ₹226.06 crores in FY2023 to ₹236.23 crores in FY2024, alongside a rise in profit from ₹9.75 crores to ₹14.79 crores, reflecting effective operational management. The sector outlook is favorable, as the demand for refrigerant and industrial gases continues to grow, driven by various industries including automotive and electronics.
The IPO valuation, priced between ₹85 and ₹90 per share, aims to raise approximately ₹199.45 crores, suggesting a reasonable entry point given the company’s growth trajectory and projected earnings per share (EPS) of ₹2.54. Growth prospects remain strong as Stallion India plans to enhance production capabilities and expand its market reach. However, potential risk factors include fluctuations in raw material prices and regulatory challenges that could impact profitability. A long-term investment horizon is advisable as Stallion India seeks to capitalize on favorable trends in the chemical industry.
| Date | GMP | Trend |
|---|---|---|
| 22 Jan 2025 11.04 | ₹40 | --- |
| 21 Jan 2025 11.03 | ₹40 | --- |
| 20 Jan 2025 11.42 | ₹40 | --- |
| 18 Jan 2025 11.29 | ₹40 | --- |
| 17 Jan 2025 11.28 | ₹40 | Down |
| 16 Jan 2025 11.10 | ₹50 | Up |
| 15 Jan 2025 12.11 | ₹30 | --- |
FAQs
The Grey Market Premium showed good accuracy in predicting Stallion India Fluorochemicals’ listing performance. While the GMP of ₹40 predicted a premium of 44.44% over the issue price, the stock delivered a gain of 33.33%. With a relatively small prediction error of 7.69%, the GMP effectively captured both the positive listing direction and approximate magnitude of gains.
Stallion India IPO Current GMP is ₹40.
Stallion India IPO Expected Returns is 44.44%.
Stallion India IPO estimated listing price is ₹130.